Antibodies from recovered patients recognize a lesser-known site on the pandemic coronavirus and block infection in lab studies
More study is needed to know whether this change improves antiviral defenses or causes harmful inflammation, UW Medicine researchers say.
Computer-designed, synthetic miniproteins act as potent, stable antivirals that block coronavirus infection of cultured human cells.
